Disease response and patient-reported outcomes among initiators of ixekizumab.
Shahriari M, Harrison RW, Burge R, Lin CY, Malatestinic WN, Goldblum OM, McLean RR, Crabtree MM, O'Brien J, Grace EL, Murage MJ.
Shahriari M, et al. Among authors: harrison rw.
J Dermatolog Treat. 2022 May;33(3):1538-1546. doi: 10.1080/09546634.2020.1853023. Epub 2020 Dec 2.
J Dermatolog Treat. 2022.
PMID: 33267635